ABCB4 and liver disorder: In several rodent models of liver disease, including the mdr2(−/−) mouse model of PSC and PFIC3, NorUDCA has been shown to be more effective than UDCA in preventing liver disease progression, and there is some evidence that NorUDCA may have anti-fibrotic effects (107, 108).